Relay Therapeutics' (RLAY) RLY-2608 An Interesting Opportunity - Citizens
Tweet Send to a Friend
Citizens analyst Silvan Tuerkcan reiterated a Market Outperform rating and $12.00 price target on Relay Therapeutics (NASDAQ: RLAY).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
